21st century cell culture for 21st century toxicology

Chemical Research in Toxicology

Volumn 30, Issue 1, 2017, Pages 43-52

  Pamies, David ^a   Hartung, Thomas ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; EXTRACELLULAR MATRIX; HUMAN; MEASUREMENT; NONHUMAN; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; STANDARD; STANDARDIZATION; STEM CELL; TECHNOLOGY; TISSUE CULTURE; TOXICOLOGY; VALIDATION STUDY; CELL CULTURE TECHNIQUE; PROCEDURES; REPRODUCIBILITY; STANDARDS;

CELL CULTURE TECHNIQUES; HUMANS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; TOXICOLOGY;

EID: 85015134000     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/acs.chemrestox.6b00269     Document Type: Review

References (84)

1. http://www.understandinganimalresearch.org.uk/animals/numbers-animals/.
2. Daneshian, M., Busquet, F., Hartung, T., and Leist, M. (2015) Animal use for science in Europe. ALTEX 32, 261-274.
3. Rovida, C., Asakura, C., Daneshian, M., Hofman-Huether, H., Leist, M., Meunier, L., Reif, D., Rossi, A., Schmutz, M., Valentin, J.-P., Zurlo, J., and Hartung, T. (2015) Toxicity testing in the 21st century beyond environmental chemicals. ALTEX 32, 171-181.
4. Suter-Dick, L., Alves, P. M., Blaauboer, B. J., Bremm, K.-D., Brito, C., Coecke, S., Flick, B., Fowler, P., Hescheler, J., Ingelman-Sundberg, M., Jennings, P., Kelm, J. M., Manou, I., Mistry, P., Moretto, A., Roth, A., Stedman, D., van de Water, B., and Beilmann, M. (2015) Stem cellderived systems in toxicology assessment. Stem Cells Dev. 24, 1284-1296.
5. Marx, U., Anderson, T. B., Bahinski, A., Beilmann, M., Beken, S., Cassee, F. R., Cirit, M., Daneshian, M., Fitzpatrick, S., Frey, O., Gaertner, C., Giese, C., Griffith, L., Hartung, T., Heringa, M. B., Hoeng, J., de Jong, W. H., Kojima, H., Kuehnl, J., Luch, A., Maschmeyer, I., Sakharov, D., Sips, A. J. A. M., Steger-Hartmann, T., Tagle, D. A., Tonevitsky, A., Tralau, T., Tsyb, S., van de Stolpe, A., Vandebriel, R., Vulto, P., Wang, J., Wiest, J., Rodenburg, M., and Roth, A. (2016) Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing. ALTEX 33, 272-321.
6. Hartung, T. (2009) Toxicology for the twenty-first century. Nature 460, 208-212.
7. Hartung, T., and Leist, M. (2008) Food for thought on the evolution of toxicology and phasing out of animal testing. ALTEX 25, 91-102.
8. Leist, M., Hartung, T., and Nicotera, P. (2008) The dawning of a new age of toxicology. ALTEX 25, 103-114.
9. Hartung, T. (2009) A toxicology for the 21st century: mapping the road ahead. Toxicol. Sci. 109, 18-23.
10. FDA (2001) PART 1271-Human cells, tissues, and cellular and tissue-based products, updated 2015, available at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch. cfm?CFRPart=1271 [last accessed 9 Aug 2016].
11. EU (2006) Commission Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells, Off. J. Eur. Union, L 38/40, available at http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2006:038:0040:0052:EN:PDF [last accessed 9 Aug 2016].
12. CBAT (2014) Donation of Starting Material for Cell-Based Advanced Therapies: a SaBTO Review, Advisory Committee on the Safety of Blood Tissues and Organs, Department of Health, London, UK, available at: https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/326823/Cellular-Therapy.pdf [last accessed 9 Aug 2016].
13. Scholz, D., Pöltl, D., Genewsky, A., Weng, M., Waldmann, T., Schildknecht, S., and Leist, M. (2011) Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line. J. Neurochem. 119, 957-971.
14. Aschauer, L., Limonciel, A., Wilmes, A., Stanzel, S., Kopp- Schneider, A., Hewitt, P., Lukas, A., Leonard, M. O., Pfaller, W., and Jennings, P. (2015) Application of RPTEC/TERT1 cells for investigation of repeat dose nephrotoxicity: A transcriptomic study. Toxicol. In Vitro 30, 106-116.
15. Frattini, A., Fabbri, M., Valli, R., De Paoli, E., Montalbano, G., Gribaldo, L., Pasquali, F., and Maserati, E. (2015) High variability of genomic instability and gene expression profiling in different HeLa clones. Sci. Rep. 5, 15377.
16. Kleensang, A., Vantangoli, M., Odwin-DaCosta, S., and ersen, M. E., Boekelheide, K., Bouhifd, M., Fornace, A. J., Jr, Livi, C. B., Madnick, S., Maertens, A., Zhao, L., Rosenberg, M., Yager, J. D., and Hartung, T. (2016) Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell function. Sci. Rep. 6, 28994.
17. Marx, V. (2014) Cell-line authentication demystified. Nat. Methods 11, 483-488.
18. Andrews, P. W., Arias-Diaz, J., and Auerbach, J. (2009) Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev. Rep. 5, 301-314.
19. Coecke, S., Ahr, H., Blaauboer, B. J., Bremer, S., Casati, S., Castell, J., Combes, R., Corvi, R., Crespi, C. L., Cunningham, M. L., Elaut, G., Eletti, B., Freidig, A., Gennari, A., Ghersi-Egea, J.-F., Guillouzo, A., Hartung, T., Hoet, P., Ingelman-Sundberg, M., Munn, S., Janssens, W., Ladstetter, B., Leahy, D., Long, A., Meneguz, A., Monshouwer, M., Morath, S., Nagelkerke, F., Pelkonen, O., Ponti, J., Prieto, P., Richert, L., Sabbioni, E., Schaack, B., Steiling, W., Testai, E., Vericat, J.-A., and Worth, A. (2006) Metabolism: a bottleneck in in vitro toxicological test development. Altern. Lab. Anim. 34, 49-84.
20. Hartung, T. (2007) Food for thought on cell culture. ALTEX 24, 143-152.
21. Hartung, T. (2013) Look Back in anger - what clinical studies tell us about preclinical work. ALTEX 30, 275-291.
22. Drexler, H. G., Uphoff, C. C., Dirks, W. G., and Macleod, R. A. F. (2002) Mix-ups and mycoplasma: the enemies within. Leuk. Res. 26, 329-333.
23. Drexler, H. G., and Uphoff, C. C. (2002) Mycoplasma contamination of cell cultures: incidence, sources, effects, detection, elimination, prevention. Cytotechnology 39, 75-90.
24. Ye, F., Chen, C., Qin, J., Liu, J., and Zheng, C. (2015) Genetic profiling reveals an alarming rate of cross-contamination among human cell lines used in China. FASEB J. 29, 4268-4272.
25. http://www.hpacultures.org.uk/services/celllineidentityverification/misidentifiedcelllines.jsp
26. Hay, R. J., Macy, M. L., and Chen, T. R. (1989) Mycoplasma infection of cultured cells. Nature 339, 487-488.
27. Pinheiro de Oliveira, T. F., Fonseca, A. A., Camargos, M. F., de Oliveira, A. M., Pinto Cottorello, A. C., Souza, A. D. R., de Almeida, I. G., and Heinemann, M. B. (2013) Detection of contaminants in cell cultures, sera and trypsin. Biologicals 41, 407-414.
28. Kumar, A., and Yerneni, L. K. (2009) Semi-automated relative quantification of cell culture contamination with mycoplasma by photoshop-based image analysis on immunofluorescence preparations. Biologicals 37, 55-60.
29. Armstrong, S. E., Mariano, J. A., and Lundin, D. J. (2010) The scope of mycoplasma contamination within the biopharmaceutical industry. Biologicals 38, 211-213.
30. Baker, M. (2016) 1, 500 scientists lift the lid on reproducibility. Nature 533, 452-454.
31. Hartung, T., Stephens, M., and Hoffmann, S. (2013) Mechanistic validation. ALTEX 30, 119-130.
32. Andersen, M., Betts, K., Dragan, Y., Fitzpatrick, S., Goodman, J. L., Hartung, T., Himmelfarb, J., Ingber, D. E., Jacobs, A., Kavlock, R., Kolaja, K., Stevens, J. L., Tagle, D., Taylor, D. L., and Throckmorton, D. (2014) Developing microphysiological systems for use as regulatory tools - challenges and opportunities. ALTEX 31, 364-367 extended online version available at http://www.altex.ch/resources/altex-2014-3-Suppl-Andersen.pdf.
33. Paschos, N. K., Brown, W. E., Eswaramoorthy, R., Hu, J. C., and Athanasiou, K. A. (2015) Advances in tissue engineering through stem cell-based co-culture. J. Tissue Eng. Regener. Med. 9, 488-503.
34. Franks, T. J., Colby, T. V., Travis, W. D., Tuder, R. M., Reynolds, H. Y., Brody, A. R., et al. (2008) Resident cellular components of the human lung: current knowledge and goals for research on cell phenotyping and function. Proc. Am. Thorac. Soc. 5, 763-766.
35. D'Arcangelo, E., and McGuigan, A. P. (2015) Micropatterning strategies to engineer controlled cell and tissue architecture in vitro. BioTechniques 58, 13-23.
36. Oliveira, S. M., Reis, R. L., and Mano, J. F. (2015) Towards the design of 3D multiscale instructive tissue engineering constructs: Current approaches and trends. Biotechnol. Adv. 33, 842-855.
37. Parrish, A. R., Gandolfi, A. J., and Brendel, K. (1995) Precisioncut tissue slices: applications in pharmacology and toxicology. Life Sci. 57, 1887-1901.
38. Gahwiler, B. H., Capogna, M., Debanne, D., McKinney, R. A., and Thompson, S. M. (1997) Organotypic slice cultures: a technique has come of age. Trends Neurosci. 20, 471-477.
39. Fisher, R. L., and Vickers, A. E. (2013) Preparation and culture of precision-cut organ slices from human and animal. Xenobiotica 43, 8-14.
40. Huang, Y., Williams, J. C., and Johnson, S. M. (2012) Brain slice on a chip: opportunities and challenges of applying microfluidic technology to intact tissues. Lab Chip 12, 2103-2117.
41. Layer, P. G., Robitzki, A., Rothermel, A., and Willbold, E. (2002) Of layers and spheres: the reaggregate approach in tissue engineering. Trends Neurosci. 25, 131-134.
42. Kelm, J. M., and Fussenegger, M. (2004) Microscale tissue engineering using gravity-enforced cell assembly. Trends Biotechnol. 22, 195-202.
43. Hartung, T., and Wendel, A. (1991) Endotoxin-inducible cytotoxicity in liver cell cultures - I. Biochem. Pharmacol. 42, 1129-1135.
44. Hartung, T., and Wendel, A. (1992) Endotoxin-inducible cytotoxicity in liver cell cultures - II: demonstration of endotoxintolerance. Biochem. Pharmacol. 43, 191-196.
45. Alépée, N., Bahinski, T., Daneshian, M., De Wever, B., Fritsche, E., Goldberg, A., Hansmann, J., Hartung, T., Haycock, J., Hogberg, H., Hoelting, L., Kelm, J. M., Kadereit, S., McVey, E., Landsiedel, R., Leist, M., Lübberstedt, M., Noor, F., Pellevoisin, C., Petersohn, D., Pfannenbecker, U., Reisinger, K., Ramirez, T., Rothen-Rutishauser, B., Schäfer-Korting, M., Zeilinger, K., and Zurich, M.-G. (2014) Stateof- the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology - a t4 report. ALTEX 31, 441-477.
46. Hogberg, H. T., Bressler, J., Christian, K. M., Harris, G., Makri, G., O'Driscoll, C., Pamies, D., Smirnova, L., Wen, Z., and Hartung, T. (2013) Toward a 3D model of human brain development for studying gene/environment interactions. Stem Cell Res. Ther. 4 (Suppl 1), S4.
47. Lancaster, M. A., Renner, M., Martin, C. A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., and Knoblich, J. A. (2013) Cerebral organoids model human brain development and microcephaly. Nature 501, 373-379.
48. Zhang, Y. S., Aleman, J., Arneri, A., Bersini, S., Piraino, F., Shin, S. R., Dokmeci, M. R., and Khademhosseini, A. (2015) From cardiac tissue engineering to heart-on-a-chip: beating challenges. Biomed Mater. 10, 034006.
49. Jastrzebska, E., Tomecka, E., and Jesion, I. (2016) Heart-on-achip based on stem cell biology. Biosens. Bioelectron. 75, 67-81.
50. Kim, H. J., Li, H., Collins, J. J., and Ingber, D. E. (2016) Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-ona- chip. Proc. Natl. Acad. Sci. U. S. A. 113, E7-15.
51. Graf, B. W., and Boppart, S. A. (2010) Imaging and analysis of three-dimensional cell culture models. Methods Mol. Biol. 591, 211-227.
52. Whitesides, G. M. (2006) The origins and the future of microfluidics. Nature 442, 368-373.
53. Marx, U., Walles, H., Hoffmann, S., Lindner, G., Horland, R., Sonntag, F., Klotzbach, U., Sakharov, D., Tonevitsky, A., and Lauster, R. (2012) Human-on-a-chip" developments: a translational cuttingedge alternative to systemic safety assessment and efficiency evaluation of substances in laboratory animals and man? Altern. Lab. Anim. 40, 235-257.
54. Koppelstaetter, C., Jennings, P., Ryan, M. P., Morin, J. P., Hartung, T., and Pfaller, W. (2004) Assessment of a new cell culture perfusion apparatus for in vitro chronic toxicity testing. Part 1: Technical description. ALTEX 21, 51-60.
55. Jennings, P., Koppelstaetter, C., Pfaller, W., Morin, J. P., Hartung, T., and Ryan, M. P. (2004) Assessment of a new cell culture perfusion apparatus for in vitro chronic toxicity testing. Part 2: Toxicological evaluation. ALTEX 21, 61-66.
56. Hartung, T. (2014) 3D - a new dimension of in vitro research. Adv. Drug Delivery Rev. 69, vi.
57. Huh, D., Leslie, D. C., Matthews, B. D., Fraser, J. P., Jurek, S., Hamilton, G. A., Thorneloe, K. S., McAlexander, M. A., and Ingber, D. E. (2012) A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci. Transl. Med. 4, 159ra147.
58. Rossini, G. P., and Hartung, T. (2012) Towards tailored assays for cell-based approaches to toxicity testing. ALTEX 29, 359-372.
59. Kirkland, D., Aardema, M., Henderson, L., and Müller, L. (2005) Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and noncarcinogens. Mutat. Res., Genet. Toxicol. Environ. Mutagen. 584, 1-256.
60. Kleensang, A., Maertens, A., Rosenberg, M., Fitzpatrick, S., Lamb, J., Auerbach, S., Brennan, R., Crofton, K. M., Gordon, B., Fornace, A. J., Jr., Gaido, K., Gerhold, D., Haw, R., Henney, A., Ma'ayan, A., McBride, M., Monti, S., Ochs, M. F., Pandey, A., Sharan, R., Stierum, R., Tugendreich, S., Willett, C., Wittwehr, C., Xia, J., Patton, G. W., Arvidson, K., Bouhifd, M., Hogberg, H. T., Luechtefeld, T., Smirnova, L., Zhao, L., Adeleye, Y., Kanehisa, M., Carmichael, P., and ersen, E. M., and Hartung, T. (2014) Pathways of Toxicity. ALTEX 31, 53-61.
61. Jennings, P. (2015) The future of in vitro toxicology. Toxicol. In Vitro 29, 1217-1221.
62. Mueller, S. O., Dekant, W., Jennings, P., Testai, E., and Bois, F. (2015) Comprehensive summary-Predict-IV: a systems toxicology approach to improve pharmaceutical drug safety testing. Toxicol. In Vitro 30 (1 Pt A), 4-6.
63. Wilmes, A., Bielow, C., Ranninger, C., Bellwon, P., Aschauer, L., Limonciel, A., Chassaigne, H., Kristl, T., Aiche, S., Huber, C. G., Guillou, C., Hewitt, P., Leonard, M. O., Dekant, W., Bois, F., and Jennings, J. (2015) Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics. Toxicol. In Vitro 30 (1 Pt A), 117-127.
64. Gstraunthaler, G., and Hartung, T. (1999) Bologna declaration toward Good Cell Culture Practice. Altern. Lab. Anim. 27, 206.
65. Hartung, T., Balls, M., Bardouille, C., Blanck, O., Coecke, S., Gstraunthaler, G., and Lewis, D. (2002) Report of ECVAM task force on good cell culture practice (GCCP). Altern. Lab. Anim. 30, 407-414.
66. Coecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., Hay, R., Merten, O.-W., Price, A., Schechtman, L., Stacey, G., and Stokes, W. (2005) Guidance on Good Cell Culture Practice. Altern. Lab. Anim. 33, 261-287.
67. Balls, M., Coecke, S., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., Hay, R., Merten, O. W., Price, A., Schechtman, L. M., Stacey, G., and Stokes, W. (2006) The importance of good cell culture practice (GCCP). ALTEX 23, 270-273.
68. Stacey, G. N., and Hartung, T. (2007) Availability, standardization and safety of human cells and tissues for drug screening and testing, in Drug Testing In Vitro: Breakthroughs and Trends in Cell Culture Technology (Marx, U., and Sandig, V., Eds.) pp 231-250, Wiley-VCH Verlag, Weinheim, Germany.
69. Pamies, D., Martin, U., Bal-Price, A., Stacey, G., Jennings, P., Grillari, R., Schwamborn, J., Ellinger-Ziegelbauer, C., and Hartung, T. (2016) Good Cell Culture Practice: human (stem) cells and organoids. ALTEX, .
70. Hartung, T., and Zurlo, J. (2012) Alternative approaches for medical countermeasures to biological and chemical terrorism and warfare. ALTEX 29, 251-260.
71. Mitalipova, M. M., Rao, R. R., Hoyer, D. M., Johnson, J. A., Meisner, L. F., Jones, K. L., Dalton, S., and Stice, S. L. (2005) Preserving the genetic integrity of human embryonic stem cells. Nat. Biotechnol. 23, 19-20.
72. Lund, R. J., Narva, E., and Lahesmaa, R. (2012) Genetic and epigenetic stability of human pluripotent stem cells. Nat. Rev. Genet. 13, 732-744.
73. Steinemann, D., Gohring, G., and Schlegelberger, B. (2013) Genetic instability of modified stem cells - a first step towards malignant transformation? Am. J. Stem Cells 2, 39-51.
74. Adler, S., Allsopp, T., Bremer, S., Buzanska, L., Drake, R., Frandsen, U., Gribaldo, L., Gmeiner, K., Harkness, L., Hartung, T., Healy, L., Hescheler, J., Knaut, H., Mandenius, C.-F., Pazos, P., Price, A., Pellizzer, C., Pera, M., Reubinoff, B., Stojanov, T., Strehl, R., Stummann, T., Trosko, J., Hasiwa, M., and Stacey, G. (2007) hESC Technology for Toxicology and Drug Development: Summary of Current Status and Recommendations for Best Practice and Standardization, The Report and Recommendations of an ECVAM Workshop, available at https://eurl-ecvam.jrc.ec.europa.eu/aboutecvam/archive-publications/publication/hESC-%20010711.pdf [last accessed 11 July 2016].
75. Pamies, D., Bal-Price, A., Simeonov, A., Tagle, D., Allen, D., Gerhold, D., Yin, D., Pistollato, F., Inutsuka, T., Sullivan, K., Stacey, G., Salem, H., Leist, M., Daneshian, M., Vemuri, M. C., McFarland, R., Coecke, S., Fitzpatrick, S. C., Lakshmipathy, U., Mack, A., Wang, W. B., Sekino, Y., Kanda, Y., and Hartung, T. (2016) Good Cell Culture Practice for stem cells and stem-cell-derived models. ALTEX, DOI: 10.14573/altex.1607121.
76. Leist, M., Efremova, L., and Karreman, C. (2010) Food for thought considerations and guidelines for basic test method descriptions in toxicology. ALTEX 27, 309-317.
77. Kilkenny, C. C., Browne, W. J. W., Cuthill, I. C. I., Emerson, M. M., and Altman, D. G. D. (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 8, e1000412.
78. Baker, D., Lidster, K., Sottomayor, A., and Amor, S. (2014) Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studies. PLoS Biol. 12, e1001756.
79. Hooijmans, C., de Vries, R., Leenaars, M., and Ritskes-Hoitinga, M. (2010) A gold standard publication checklist to improve the quality of animal studies, to fully integrate the Three Rs, and to make systematic reviews more feasible. Altern. Lab. Anim. 38, 167-182.
80. Hartung, T., Bremer, S., Casati, S., Coecke, S., Corvi, R., Fortaner, S., Gribaldo, L., Halder, M., Hoffmann, S., Roi, A. J., Prieto, P., Sabbioni, E., Scott, L., Worth, A., and Zuang, V. (2004) A modular approach to the ECVAM principles on test validity. ATLA - Altern Lab Anim 32, 467-472.
81. OECD (2005) Guidance Document on the Validation and International Acceptance of New or Updated Test Methods for Hazard Assessment, OECD Series on Testing and Assessment, Guidance Document 34, available at http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?doclanguage= en&cote=env/jm/mono(2005)14 [last accessed 11 July, 2016].
82. Hartung, T. (2007) Food for thought on validation. ALTEX 24, 67-72.
83. Leist, M., Hasiwa, M., Daneshian, M., and Hartung, T. (2012) Validation and quality control of replacement alternatives - current status and future challenges. Toxicol. Res. 1, 8.
84. Bottini, A. A., and Hartung, T. (2009) Food for thought on economics of animal testing. ALTEX 26, 3-16.